Biotech, Digital Ad IPOs on Calendar for First Week of March

Last week was a downer for initial public offerings. Only one — a “best efforts” deal — was on the calendar, and that one failed to launch. Perhaps the action will pick up a bit in the coming week with a couple of new IPOs scheduled to begin trading.

IPO ETF manager Renaissance Capital reported that 24 IPOs have priced in the United States so far this year, down about 35% from a year ago. Total proceeds raised come to $3.9 billion, down about 44% compared with the same period in 2014. Of the 24 IPOs that have gone off this year, 13 have come from the health care sector. Last year’s IPO total came in at $85.2 billion, the highest total in the past 10 years. Renaissance Capital does not include OTC listings or blank check companies in its IPO data.
The “best efforts” IPO that remains on the calendar is Wowo Ltd., a China-based lifestyle, e-commerce platform. The company plans to offer 6 million shares in an expected price range of $9 to $11, raising $60 million at a market cap of around $384 million. The offering is being made on a “best efforts” basis and is not tracked by Renaissance Capital. The sole bookrunner on the offering is Axiom Capital Management. Shares are listed as “day-to-day” and will trade on the Nasdaq under the ticker symbol WOWO.
ALSO READ: Is Alibaba Headed Back to the IPO Price or Lower as Lock-Up Expirations Near?
Summit Therapeutics PLC is a U.K.-based biopharmaceutical company developing novel therapeutics for muscular dystrophy and bacterial infections. The company plans to offer 3.45 million American depositary shares (ADS) at $11.54 per ADS to raise approximately $40 million at a market cap of about $130 million. One ADS is equal to five ordinary shares. Joint bookrunners for the offering are JMP Securities and Oppenheimer. The sole co-manager is Needham. The offering is listed as taking place next week, and ADSs will trade on the Nasdaq under the ticker symbol SMMT.
MaxPoint Interactive Inc. is a digital advertising automation platform that enables national brands to drive local, in-store sales. The company plans to offer 6.5 million shares in an expected price range of $10.50 to $12.50 to raise about $75 million at a market cap of $294 million. Joint bookrunners for the IPO are Goldman Sachs, Deutsche Bank and Pacific Crest. Co-managers are Needham and William Blair. The offering is expected to price on Thursday and begin trading Friday on the New York Stock Exchange under the ticker symbol MXPT.

By Paul Ausick February 28, 2015 9:25 am EST

Source:http://247wallst.com/investing/2015/02/28/biotech-digital-ad-ipos-on-calendar-for-first-week-of-march/